Condition: Autism Spectrum Disorder · Sponsor: Medical University of Warsaw
In this trial, the investigators aim to evaluate the impact of a multispecies probiotic consisting of Bacillus subtilis W201, Bifidobacterium infantis W17, Bifidobacterium lactis W51, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus rhamnosus W140, Lactococcus lactis W19, Propionibacterium freudenreichii W200, on the severity of autism symptoms, quality of life, gastrointestinal symptoms, sleep disturbances, parental stress levels and urinary p-cresol concentrations in children with Autism Spectrum Disorder aged 7 to 15 years.
This description comes directly from the study's public registry record.
Maja Kotowska, MD · +48223179536 · kotowska.maja@gmail.com
Jan Łukasik, MD, PhD · +48223179536 · jan.lukasik@wum.edu.pl
Always discuss trial participation with your own doctor first.
| Department of Paediatrics, The Medical University of Warsaw | Warsaw, Warsaw, Poland | Recruiting |
| Department of Paediatrics, The Medical University of Warsaw | Warsaw, Warsaw, Poland | Recruiting |
| Department of Paediatrics, The Medical University of Warsaw | Warsaw, Warsaw, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06448767